Euthymics Bioscience euthymics.com


Public lists: Pharma Startups (4740)

Euthymics Bioscience is developing a novel medicine for alcohol use disorder (AUD) and smoking cessation. The name Euthymics is related to the word "euthymia" which means "mood in the 'normal' range, without manic or depressive symptoms." Euthymics Bioscience is focused on developing therapeutics that help patients with withdrawal symptoms, impulsivity and cravings, all of which are common when being treated for addiction.

Euthymics Bioscience is developing a novel medicine for alcohol use disorder (AUD) and smoking cessation. The name Euthymics is related to the word "euthymia" which means "mood in the 'normal' range, without manic or depressive symptoms." Euthymics B...Show all

Company (Alive / Active)

Phone: 484-856-2791

Fax:

116 Research Drive

Bethlehem, 18015
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Euthymics Bioscience $28.3M Jun 1, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Euthymics Bioscience Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Polymorphs of azabicyclohexane Sep 21, 2015 Sep 26, 2017 Patent
1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments Jul 17, 2015 Mar 21, 2017 Patent
Combinations and methods Jul 01, 2014 Feb 14, 2017 Patent
Process for the synthesis of (+) and (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane Jul 18, 2013 Dec 27, 2016 Patent
Polymorphs of azabicyclohexane May 31, 2013 Sep 22, 2015 Patent
See all 9 patents